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Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a rare disease typified by ventricular arrhythmias precipitated by elevated adrenaline levels, which often occur during emotional stress or physical exercise (1) . Although a number of genetic mutations have been associated with CPVT, the most common are variants found in the gene that encodes the ryanodine receptor-2 (RyR2). In cardiac myocytes, RyR2 plays a critical role in excitation-contraction by acting as an intracellular calcium channel that mediates the release of calcium from the sarcoplasm, which, in response. increases intracellular calcium levels. Calcium entry into the cell is regulated by L-type voltage gated calcium channels (LVGCCs), which are located in the cellular membrane. It has been known for some time that the gating of LVGCC Ca V 1.2 subunit is indirectly modulated by β-adrenergic receptors, which enhance calcium influx via activation of protein kinase A. Therefore, in cases where mutations in RyR2 lead to a gain of function, activation of the adrenergic signaling pathway can trigger a regenerative dysregulation of calcium homeostasis and subsequent arrhythmia. In patients with CPVT, these ventricular arrhythmias can result in sudden cardiac failure and death.
Currently there are approximately 150 RyR2 mutations linked to CPVT. A number of RyR2 gain-of-function mutations have been identified. These are often referred to as "leaky" mu-tations in that the channels exhibit increased open probability and often permit non-evoked calcium release. In many cases, the mutations are point mutations in which a single amino acid is miscoded. The identification of specific point mutations associated with CPVT has enabled investigators to genetically engineer mice with the same mutations in an attempt to better understand the underlying mechanism(s) that give rise to the pathophysiology. One such mutation, the R176Q mutation first described in 2002 (2) has been demonstrated to produce catecholamine-induced ventricular tachycardia and cardiomyopathy in mice (3) .
Because RyR2 is also expressed in neurons, it seems reasonable to hypothesize that mutations that disrupt cardiac function would also be likely to alter neuronal function. A recent study by Aiba and colleagues presents a series of experiments that test this hypothesis directly. Using the same knockin mice (3) that carry a single RyR2 R176Q, the authors examined the impact of the RyR2 R176Q mutation on rhythmic cortical activity, brainstem function, intrinsic neuronal excitability, and neurotransmitter release.
Although the RQ mice rarely exhibit overt behavioral or electrographic seizures, chronic EEG recordings detected spontaneous bilateral cortical epileptiform spike discharges in the mutant mice. In addition, several (three of five) of the RQ mice exhibited bradycardia and atrioventricular block, though these cardiac events were not coincident with the abnormal EEG activity. Activation of the RyR2 receptor by systemic injection of caffeine produced cardiac fibrillation and arrest in RQ mutant mice, which proved to be lethal in all five mice that were examined. In contrast, none of the wild-type mice died Cardiorespiratory failure is the most common cause of sudden unexplained death in epilepsy (SUDEP). Genetic autopsies have detected "leaky" gain-of-function mutations in the ryanodine receptor-2 (RyR2) gene in both SUDEP and sudden cardiac death cases linked to catecholaminergic polymorphic ventricular tachycardia that feature lethal cardiac arrhythmias without structural abnormality. Here we find that a human leaky RyR2 mutation, R176Q (RQ), alters neurotransmitter release probability in mice and significantly lowers the threshold for spreading depolarization (SD) in dorsal medulla, leading to cardiorespiratory collapse. Rare episodes of sinus bradycardia, spontaneous seizure, and sudden death were detected in RQ/+ mutant mice in vivo; however, when provoked, cortical seizures frequently led to apneas, brainstem SD, cardiorespiratory failure, and death. In vitro studies revealed that the RQ mutation selectively strengthened excitatory, but not inhibitory, synapses and facilitated SD in both the neocortex as well as brainstem dorsal medulla autonomic microcircuits. These data link defects in neuronal intracellular calcium homeostasis to the vulnerability of central autonomic brainstem pathways to hypoxic stress and implicate brainstem SD as a previously unrecognized site and mechanism contributing to premature death in individuals with leaky RYR2 mutations.
Leaks That Could Kill
after treatment with caffeine. These data seem to suggest that the RyR2 R176Q mutation pushes the brain to a more seizureprone state that, once provoked, tips over into ictal activity. To further explore this concept, Aiba and colleagues carried out several in vitro experiments designed to quantify the extent to which spreading depolarization (SD) might be a contributing factor to the aberrant neuronal activity observed in the RQ mutant mice. Spreading depolarization has been implicated in several ion channelopathy mouse models as a potential contributing factor in sudden unexpected death in epilepsy (SUDEP) (4).
To characterize SD, the authors used a combination of local field potential recording and intrinsic optical signaling, which provided them with a fairly high degree of spatial and temporal resolution. Using three different methods to induce seizure-like episodes in vitro, the authors were able to demonstrate that cortical slices prepared from RQ mice 1) exhibited a more rapid SD onset, 2) had SD bouts that were more frequent and lasted longer, and 3) exhibited higher rates of SD propagation. These observations were pretty much consistent regardless of the method used to induce the seizure-like activity. The authors also demonstrated that SD is enhanced in the RQ mice in vivo. Importantly, ictal activity provoked in the cortex produced SD in the brainstem, which was accompanied by agonal breathing, cardiac arrhythmia, and, in five of seven mice, death. This is in contrast to the wild-type controls in which no lethality was observed. Furthermore, the authors present data from in vitro experiments using brainstem slices demonstrating that the dorsal vagal complex in the RQ mice had a lower SD threshold. Collectively, these results led the authors to conclude: "Although the lack of systemic physiological monitoring of oxygen saturation and blood pressure during these recordings is a potential caveat, these results indicate that the RQ mouse is highly susceptible to seizure-induced lethality, likely due to hypoxia/hypoxemia resulting from peri-ictal cardiorespiratory instability and a lower threshold for SD within the central autonomic microcircuitry. "
But how do leaky RyR2 complexes lead to such profound changes in network stability? To address this question, the authors first examined the intrinsic membrane properties of layer II/III pyramidal neurons in the somatosensory cortex. Using standard whole-cell current clamp methodology, the authors demonstrated that the passive and active membrane properties are by and large unaltered. One exception is the post-burst after hyperpolarization (AHP). The authors found that the peak of the post-burst AHP increased. The post-burst AHP is thought to limit repetitive action potential firing in response to sustained depolarizing currents and thus regulates neural excitability. Therefore, the authors suggest that the increase in AHP amplitude is not a contributing mechanism but instead appears to be a compensatory response. Next, the authors evaluated basic synaptic transmission in the RQ mice. When evoked release probability was assessed using a paired-pulse protocol in the somatosensory cortex, the authors observed a modest but significant increase in the RQ mice. In addition, the authors demonstrated that the amplitude of non-evoked miniature excitatory postsynaptic currents is modestly enhanced in the RQ mice in pyramidal neurons in the cortex and dorsomotor vagal neurons in the brainstem. While it remains unclear if the enhanced excitatory drive observed in the RQ mice is the only mechanism that underlies lower seizure/SD threshold, it seems likely to be a contributing factor.
Many proteins expressed in the brain are also expressed in the heart, and in recent years there has been a growing appreciation of the link between neuronal hypersynchrony, cardiac arrhythmias, and SUDEP (5) . The data presented by Aiba and colleagues suggest that brainstem SD is a key factor in lethality following evoked seizure in the RQ mutant mice. However, it remains unclear to what extent the lethality is driven by the leaky RyR2 expressed in the brain versus the heart. In the absence of a patient population, using mice in which the mutation is heterozygous and global makes sense, as this would be likely to mimic the putative patient genetics. To address the question of relative contributions of neural versus cardiac mutations, future mouse models will need to be engineered to permit conditional, cell type specific deletions. Conditional point mutant mice where developed as early as 2006 (e.g. (1)) and since then methods for engineering inducible point mutants have become more efficient (e.g. (2)). Given the ever growing list of cre recombinase expressing "driver lines" restricting expression of the gain of function RyR2 mutation to the heart or brain appears like the obvious next step.
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